chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after the vaccine I had a low-grade fever and felt bad. I was extremely fatigued and I felt weak. It almost felt like the flu. I had nausea at night and I felt flushed. I consulted with  Urgent Care and they asked me to come in and get a COVID-19 test which was negative. Those symptoms lasted a full week. My period is also out of sync and it lasted longer than usual for a total of two weeks. It kept coming and going. It normally only lasts five days and it is consistent. I was also having cramping on my left lower abdominal region.
Grandmother states infant was being held, started shaking like seizure, stopped breathing, resumed breathing on own after tactile stimulation by grandmother. Was taken to emergency room at Kaweah Delta District Hosp.
Pneumonia due to COVID-19 virus Chronic respiratory failure with hypoxia (HCC) Shortness of breath  remdesivir
Patient came in for the 3rd vaccine for Pfizer. She indicated on the attestation form that she was 18-64 and signed for  it. I did not calculate the age from the birthday and realized she was 17 after administering the vaccine. The third vaccine or booster for Pfizer was approved for 18 and over. She had mild side effects from the first two Pfizer vaccines.
Weak mussels, particularly legs. Fell down, even using a walker.  X-ray of possible broken collarbone showed only a bruise. This was done at hospital emergency room. Also very tired and slept most of day. Was getting up for supper when fall occurred.
Acne; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Acne) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACNE (Acne). The patient was treated with DOXYCYCLINE ongoing since an unknown date for Acne, at an unspecified dose and frequency. At the time of the report, ACNE (Acne) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported .  Caller stated that she, Knows a lot of people on antibiotics who get the vaccine
There is no adverse event. Nurse gave client .25 cc dose of flu instead of .5 cc dose per child's age.
Patient received an additional dose of the influenza vaccine for the flu season of 2021/22. Patient accidentally signed up for flu vaccine when she actually wanted a Covid booster.
Next day post vax, the pt developed stomach pain, diarrhea, general achiness, and headache. No treatment was given.
soreness on the arm of the injection; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness on the arm of the injection) and FATIGUE (felt tired) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal, Blood cholesterol abnormal and Prostate cancer.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness on the arm of the injection) and FATIGUE (felt tired). At the time of the report, VACCINATION SITE PAIN (soreness on the arm of the injection) and FATIGUE (felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified blood pressure and cholesterol medication. No treatment information was provided. The patient is going to have a surgery on 09-APR-2021.
CURRENT CANCER; NOT FEELING WELL IN GENERAL; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: radiation, and chemotherapy, and concurrent conditions included: colon cancer (from 5 years ago), non alcoholic, and smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s  (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 04ZAZ1A expiry: UNKNOWN) dose was not reported, 1 total, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 06-APR-2021, the patient was not feeling well in general and was in bed for 2 days post initial vaccine. On 30-APR-2021, the patient experienced current cancer (swollen lymph node shortly after the first dose) (Dose number in series 1).  The lung doctor found swollen lymph node growing on the artery connecting the heart to the lungs right side in APR-2021. He had undergone radiation and chemotherapy for this. It was inoperable because of current position of lymph node. Doctors found it strange to get two types of cancer like the patient had back to back. Currently under the care of the Oncologists at the local Cancer Centre in his city. Patient now worried that the vaccine was linked to current swollen lymph node and current cancer. The patient received booster covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 213D21A expiry: UNKNOWN) dose was not reported, 1 total administered on 23-NOV-2021 for prophylactic vaccination.  It was unknown whether patient had any adverse events following vaccination (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from not feeling well in general, and had not recovered from current cancer. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20220647124-COVID-19 VACCINE AD26.COV2.S- Current Cancer. The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related.
Information has been received from a pharmacist concerning a 61 year old female with penicillin allergy who on 06-SEP-2010 was vaccinated SC with 0.65 ml ZOSTAVAX (Merck) (single dose). On 08-SEP-2010 the patient called the pharmacy complaining of a two inch by three inch area, centered on the injection site, that she described as warm, swollen, hard and cyst-like. Medical attention was sought by calling pharmacist. At the time of the report, the patient status was not reported. Follow-up information was received from the pharmacist concerning the 61 year old female who on 06-SEP-2010 at 11:00 AM was vaccinated SC in the left arm with the first dose of ZOSTAVAX (Merck) (lot # 664670/0151Z) at a pharmacy. On 08-SEP-2010 AM the patient experienced 2 inch x 3 inch warm, swollen, tender, hard (cyst-like) (duration unknown). At the time of the report, the outcome of the events was unknown. Additional information has been requested.
Information has been received from a nurse concerning a her daughter 19 year old with "allergic sulfa" and no pertinent medical history who on 18-JUN-2008 was vaccinated with a first dose of GARDASIL. Concomitant therapy included TRI-CYCLEN and montelukast sodium (MSD). The nurse reported that her daughter developed swelling of the gums and cankers sores in the mouth following vaccination with GARDASIL. The daughter's gums swelled and she developed cankers sores 4 days after the first vaccination with GARDASIL. The daughter was treated by a dentist for the gum swelling and cankers sores. The gum swelling was characterized as necrotizing gingivitis. The canker sores developed over a period of 5 days and totaled 7. The gum swelling and canker sores made it hard to eat and the daughter did not eat any solid food for one week. Swelling of the gums and cankers sores in the mouth and necrotizing gingivitis was considered to be disabling. No lab diagnostics were performed. On 06-JUL-2008 the patient recovered. There was no product quality complaint. Additional information has been requested. 8/11/08-records received for DOS 6/28/08 college physical exam normal no complaints.
chills; severe severe headache, just pounding; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and HEADACHE (severe severe headache, just pounding) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (chills) and HEADACHE (severe severe headache, just pounding). At the time of the report, CHILLS (chills) and HEADACHE (severe severe headache, just pounding) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment medication was reported.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was stating that she was having a lot of pain and her arm was swollen and was having some redness. Spoke with patient today 12/03/2018, Asked patient on how she was feeling. Patient stated that she was feeling a lot better and the pain went away and the swelling went down.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 67 year old male patient who received SHINGRIX (batch number ZN22Z, expiry date 2nd February 2021) for prophylaxis. On 9th July 2018, the patient received SHINGRIX .5 ml. On an unknown date, 2 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling, injection site pustule, shingles, pain in arm, drowsiness and fever. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site pustule, shingles, drowsiness and fever were unknown and the outcome of the pain in arm was recovering/resolving. It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site pustule, shingles, pain in arm, drowsiness and fever to be related to SHINGRIX. Additional details were reported as follows: The healthcare professional reported the patient developed drowsiness, fever and arm pain same day of injection. The healthcare professional also reported patient developed redness, swelling and pustules around injection site two days after administration. The patient reportedly went to physician who diagnosed the patient as having shingles. No further information was reported regarding the event.
IPV given instead of Prevnair13. Patient also received vaxelis which also contains IPV
DONOR REPORTED SEVERAL WELTS APPEARED ONLY ON HIS L ARM WHERE SHOT WAS GIVEN THE DAY AFTER RECEIVING THE IMMUNIZATION. DONOR STATES THE WELTS LASTED FOR 2 DAYS AND  RESOLVED  ON THEIR OWN. DONOR DID NOT SEEK MEDICAL TX .
I have been having trouble catching my breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I have been having trouble catching my breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced DYSPNOEA (I have been having trouble catching my breath). At the time of the report, DYSPNOEA (I have been having trouble catching my breath) outcome was unknown.            No concomitant medications were provided by reporter. No treatment medications were provided by reporter.
Information has been received from a consumer referring to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (route, lot#, dose and frequency were unknown). On unknown dates the patient developed 4 cases of shingles. The outcome of the adverse event was unknown. The relationship of the adverse event and ZOSTAVAX was not reported. Additional information is not expected as there was no specific contact information.
Sore Arm; chills; Fever; Headache; A spontaneous report was received from a consumer concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, chills, fever, headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 25 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events sore arm, chills, fever, and headache.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event sore arm, chills, fever, and headache was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Shingles across ribs under my left shoulder blade; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 12:15 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient experienced shingles across ribs under left shoulder blade. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event shingles across ribs under left shoulder blade and included treatment with antiviral medication (unspecified). The clinical outcome of the event shingles across ribs under left shoulder blade was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 4:01 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 4:01 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 32.09. Concomitant products were not provided. Treatment medications were not reported.  Batch number 007C21A underwent temperature excursion on 29-Apr-2021 with temperature 33 degrees Fahrenheit at 10:00 AM. Total 5 vials were moved to fridge on 19-Apr-2021 and beyond use date for the vial was reported as 19-May-2021. Product moved to clinic on 29-Apr-2021.  On 29-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 36, 10 AM: 33, 11 AM: 44, 12 AM: 45, 1PM: 45, 2 PM: 44, 3 PM: 45 and 4 PM: 44.   The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.   This case was linked to MOD-2022-566976 (Patient Link).
Headache, HYPERtension, TIRED/EXHAUSTED Narrative: STATES HE CALLED OUT FROM WORK STATING HE FELT TIRED AND WANTED TO REST TODAY.
Heavy vaginal bleeding with golf ball size clots started 01/21/21 received Covid-19 vaccine 2nd dose on 01/15/21. Started period 2 days prior 1/13/21) to getting vaccine, cycle should've ended on the 18th but has had it for a week with excessive heavy bleeding
Within 12 hours chills vomiting fatigue aches. lasted 3 days. What I was not prepared for was under the arm that received shot my lymph nods swelled. Today is Friday 5 days from shot lymph nods still swollen.
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for weeks after the second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced ILLNESS (Sick for weeks after the second shot). At the time of the report, ILLNESS (Sick for weeks after the second shot) outcome was unknown. Event was stated for group of people and Start Date of event Sick for weeks after the second shot stated 2021. No concomitant medications were mentioned. No treatment details were reported.
Patient itching  of body and throat and asthma triggered.  Transported to hospital for further observation.  Patient did not stay the night in hospital.  She is home tonight with her husband and will return to the hospital if symptoms worsen.
No adverse effect reported; 1 dose of improperly stored VARIVAX was administered to patient on 29-MAY-2019; This spontaneous report was received from a nurse, and refers to a patient of unknown age and gender.No information was provided regarding the patient's medical history or concurrent conditions.   On 29-MAY-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, subcutaneously for prophylaxis (anatomical location was not provided). Lot number was reported as R029510, expiration date 14-OCT-2020. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT).  On an unspecified date, the administered dose underwent a temperature excursion of 18.3 Fahrenheit degrees for a time frame of 8 hours and 47 minutes. There were no previous temperature excursions reported. No adverse effects were reported.  The excursion was called by the Digital Data Logger.  Lot number R029510 is an invalid lot number for varicella virus vaccine live (oka/merck).
very mild sore arm; mild fatigue; Got vaccinated from a vial that experienced a temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very mild sore arm), FATIGUE (mild fatigue) and PRODUCT TEMPERATURE EXCURSION ISSUE (Got vaccinated from a vial that experienced a temperature excursion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (very mild sore arm), FATIGUE (mild fatigue) and PRODUCT TEMPERATURE EXCURSION ISSUE (Got vaccinated from a vial that experienced a temperature excursion). At the time of the report, PAIN IN EXTREMITY (very mild sore arm), FATIGUE (mild fatigue) and PRODUCT TEMPERATURE EXCURSION ISSUE (Got vaccinated from a vial that experienced a temperature excursion) outcome was unknown.            Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-032626 (Patient Link).
Redness/swelling/heat from shoulder to elbow. Started BACTRIM DS in the event that it is cellulitis. Started prednisone orally in the event that it is a reaction.
This child had prolonged crying 09/13/2001; inconsolable, extensive rash, fever.
Diagnosed with shingles 6 days later after receiving second dose of Moderna vaccine . Rash, itching, headache, ear ache, muscle ache, itching, dizziness, forgetfulness.
Anaphylaxis shock. Epipen administered by pharmacist within 10  minutes of receiving vaccination
Please see attached as per patient (1) Got vaccinated on Wednesday (2) Felt a bit of arm pain until end of Thursday (3) Friday, started feelin glads swell (4) Saturday, I also started to feel joint pain and fatigue (5) Sunday night, I got a high fever (6) Monday, I used homeopathic medicine to lower the fever (it ranged from as low as 98.1 to 100.4 approx). I got really bad chills when the fever spiked up again. (7) Tuesday, all symptoms continued, range of fever dropped a but (8) Wednesday morning fever was at is highest checked twice fever ranged from 100.1 to 101.4. All other symptoms continues. Homeopathic pills
Hoarseness; Congestion; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Hoarseness), NASAL CONGESTION (Congestion) and HEADACHE (headache) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included PREGABALIN (LYRICA) and ATENOLOL for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced DYSPHONIA (Hoarseness), NASAL CONGESTION (Congestion) and HEADACHE (headache). At the time of the report, DYSPHONIA (Hoarseness) and NASAL CONGESTION (Congestion) had not resolved and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The treatment information was unknown. Patient decline follow up with safety.